Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Tom Sutherland

Tom Sutherland

ID: 1b839945-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

Consultation on proposed amendments to Patent Rules

Pharma in Brief · July 18, 2021

Practice Areas

Health Care and Life Sciences

Jurisdictions

Publishing Record

Publisher Since 2021

Total Articles 1

Most Recent July 18, 2021

Cite This Author

Tom Sutherland, Norton Rose Fulbright

LexBlog Author ID:

1b839945-2619-30fb-68c4

www.lexblog.com/author/tom-sutherland

Contact

FirmNorton Rose Fulbright

Emailtom.sutherland@nortonrosefulbright.com

BlogPharma in Brief

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog